CL
64
2
AXP
69
-2
DE
46
-3
AMT
30
-6
ADSK
56
-2
CVX
26
3
CCL
62
-2
ADI
70
-6
CVS
33
-2
BF.B
50
-8
ALLE
46
5
EQR
44
5
ETR
49
-3
BSX
57
2
CRM
52
2
BRK.B
47
4
AMG
71
-3
APD
50
3
AEE
56
3
COP
44
4
CL
64
2
AXP
69
-2
DE
46
-3
AMT
30
-6
ADSK
56
-2
CVX
26
3
CCL
62
-2
ADI
70
-6
CVS
33
-2
BF.B
50
-8
ALLE
46
5
EQR
44
5
ETR
49
-3
BSX
57
2
CRM
52
2
BRK.B
47
4
AMG
71
-3
APD
50
3
AEE
56
3
COP
44
4
Financhill
Back

iShares LifePath Target Date 2040 ETF Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Buy
57

ITDD
iShares LifePath Target Date 2040 ETF

Last Price:
$35.39
Seasonality Move:
2.42%
Sell
32

INKT
MiNK Therapeutics, Inc.

Last Price:
$11.71
Seasonality Move:
-18.07%
Buy
57
iShares LifePath Target Date 2040 ETF (ITDD) is a Buy

Is iShares LifePath Target Date 2040 ETF a Buy, Sell or Hold?

  • The current iShares LifePath Target Date 2040 ETF [ITDD] share price is $35.37. The Score for ITDD is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • ITDD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $11.71. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ITDD Stock Price Chart

What is iShares LifePath Target Date 2040 ETF's stock price today?

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $11.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.

ITDD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 46.64 Sell
Chaikin Money Flow: -13204 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.06 - 35.8) Sell
Bollinger Bands (100): (34.08 - 35.58) Buy

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 45.61 Sell
Chaikin Money Flow: -20975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.89 - 12.65) Sell
Bollinger Bands (100): (12.3 - 15.28) Sell

ITDD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.67 Sell
20-day SMA: 35.47 Sell
50-day SMA: 35.39 Sell
200-day SMA: 33.13 Buy
8-day EMA: 35.61 Sell
20-day EMA: 35.55 Sell
50-day EMA: 35.31 Buy
200-day EMA: 33.63 Buy

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.32 Sell
20-day SMA: 11.56 Buy
50-day SMA: 12.92 Sell
200-day SMA: 11.86 Sell
8-day EMA: 12.05 Sell
20-day EMA: 12.05 Sell
50-day EMA: 12.68 Sell
200-day EMA: 12.23 Sell

iShares LifePath Target Date 2040 ETF Earnings Growth & ITDD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

iShares LifePath Target Date 2040 ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):